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Abstract
Background: Our primary objective was to determine the relationship between global cognitive function and
specific domains of gait and balance in a cohort of Parkinson’s disease (PD) subjects. In a secondary analysis, we
determined whether specific cognitive domains correlated with gait and balance performance.
Methods: Fourteen PD subjects (mean age 61.1 ± 7.8 years) were recruited from the Rush University Medical
Center Movement Disorders clinic. Subjects underwent clinical assessment using the motor subsection of the
Unified Parkinson’s Disease Rating Scale (UPDRS) followed by quantitative gait and balance assessments using
the APDM Mobility Lab™ system (Mobility Lab, APDM Inc., Portland, OR). Subjects completed global cognitive
testing using the Mattis Dementia Rating Scale (MDRS) as well as domain specific cognitive measures.
Spearman’s rho was used to assess correlations between cognitive measures and gait and balance function,
with False Discovery Rate (FDR) correction for multiple comparisons.
Results: Global cognitive function had the strongest correlation with stride velocity (r = 0.816, p = 0.001),
turn duration (r = −0.806, p = 0.001), number of steps to turn (r = −0.830, p = 0.001), and mean velocity of
postural sway in the medio-lateral direction (r = −0.726, p = 0.005). A significant correlation was found
between processing speed and two turning measures (turn duration, r = −0.884, p = 0.001; number of steps
to turn, r = −0.954, p < 0.001), but no other associations were found between specific cognitive domains and
gait domains.
Conclusions: This pilot study provides preliminary data regarding the association between global cognitive
function and pace-related measures of gait, turning, and postural sway. Furthermore, reduced processing
speed was found to be associated with difficulty in performing turns.
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Background
Difficulties with gait and balance in Parkinson’s disease
(PD) increase the risk of falls, institutionalization, and
death [1–3]. Research studies have established that safe
ambulation requires cortical input from areas involved
with higher cognitive function [4, 5]. Cognitive impair-
ment, especially prefrontal lobe dysfunction, has been
linked to motor disability in PD but these relationships
remain unclear [5–7].
Clinical rating scales, such as the Unified Parkinson’s
disease Rating Scale (UPDRS) [8], and measures derived
from such scales, such as the postural instability/gait dis-
turbance (PIGD) score, have been used to examine the
relationship between cognitive and motor impairment
[9]. However, these clinical scales are subject to rater
judgment and provide only limited detail because the or-
dinal fixed scores (0–4) force raters into a limited num-
ber of item choices without the ability to quantify
disease impairment or disability as continuous measures.
Thus far, these clinical scales have had limited ability to
elucidate the relationship between cognition and gait
and balance [10].
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Body-worn inertial sensors can provide a multitude
of continuous, objective measures of gait and balance
[11–13]. Wearable technology allows for measurement
and replication of relationships between gait and cog-
nition without the confounding factors of heightened
attentional load and observer effect seen in the labora-
tory [14]. Moreover, these quantitative measures can
be categorized into specific domains of gait and bal-
ance for analysis [11]. In this pilot project, we used
the APDM Mobility Lab™ (Mobility Lab, APDM Inc.,
Portland, OR), a valid and reliable measurement tool
of gait and balance [15–17], to examine motor func-
tion in a small cohort of PD subjects. Our primary
objective was to determine whether global cognitive
function correlated with specific domains of gait and
balance. Through a secondary analysis, we assessed
whether specific cognitive domains correlated with
gait and balance performance.
Methods
This cross-sectional study involved PD subjects re-
cruited from the Rush University Medical Center
(RUMC) Movement Disorders clinic. The study pro-
posal and consent were approved by the Institutional
Review Board of Rush University and met standards
for ethical human research. All PD patients met the
UK Parkinson’s disease society brain bank clinical
diagnostic criteria [18] and the diagnosis of PD was
confirmed by a movement disorders neurologist
through personal interview, medical history, physical
examination, and chart review.
Clinical and demographic data included age at time of
enrollment, age of onset, disease duration, height, and
weight. Disease severity was assessed for each subject
using the motor subscale of the UPDRS (UPDRS-III) [8]
and Hoehn and Yahr (H&Y) [19] staging in the ON
medication condition. PIGD scores were calculated by
using the arithmetic sum of items 13, 14, 15, 29, 30 of
the UPDRS [20].
The instrumented walk (i-WALK) and instrumented
sway (i-SWAY) test protocols [21, 22] were performed
using the commercially available APDM Mobility
Lab™ six inertial sensor system (Mobility Lab, APDM
Inc., Portland, OR), a sensitive, valid and reliable
measurement tool of gait and balance in the PD
population [15, 17]. The sensors were attached 4 cm
above each malleolus, at the dorsum of the wrists, on
the lumbar trunk at the level of L5, and on the upper
trunk 2 cm below the sternal notch. The i-WALK
protocol consisted of the subject walking back and
forth continuously between two points 25 ft apart for
a period of two minutes while in the ON medication
condition. All subjects performed the i-WALK with-
out an assistive device and the mean value for each
gait parameter was calculated. A total of 23 measures
were computed and categorized into four domains:
pace, arm and trunk movement, dynamic stability,
and turning (Appendix) [23]. Subjects then completed
the i-SWAY, during which they stood still with their
hands across their chest and their feet shoulder width
apart or together and their eyes opened or closed.
The protocol consisted of measuring balance with the
feet together, eyes closed, to maximize the sensitivity
of the balance testing. All assessments were com-
pleted in the ON medication condition.
After completing the i-WALK and i-SWAY, subjects
rested for approximately 1–2 h. Then, a neuropsycholo-
gist administered the Mattis Dementia Rating Scale
(MDRS) [24, 25], a test of global cognitive function. Sub-
jects also completed neuropsychological measures for
the following domains: verbal fluency, verbal memory
(immediate and delayed), processing speed, working
memory, and executive function (See Table 1).
SPSS version 16.0 was used for statistical analysis.
Spearman’s rho (r) was used to assess correlations be-
tween MDRS scores and measures of gait and balance,
as well as to assess correlations between the domain spe-
cific cognitive tests and gait and balance measures. Raw
scores from each neuropsychological test were converted
to z scores. Multiple comparisons were accounted for by
using a false discovery rate (FDR) adjustment [26] α =
0.05 [20]. FDR was considered more appropriate than
the more conservative corrections, such as Bonferonni,
as a large number of associations were under investiga-
tion [26, 27].
Results
Fourteen subjects with PD were included in the analysis
(Table 2). Subjects had a mean age of 61.1 ± 6.1 years
and disease duration of 12.7 ± 6.2 years. Mean motor
UPDRS was 21.5 ± 9.2 (ON condition) indicating that
subjects had mild to moderate disease severity. The
mean MDRS Total score was 132.2 ± 8.3, indicating that
subjects varied between largely intact cognition and mild
cognitive impairment. The MDRS Total score had the
strongest correlation with pace-related measures of gait,
turning, and postural sway in the ON condition (Table 3).
Significant correlations were found between MDRS
Total scores and stride velocity (r = 0.816, p = 0.001),
turn duration (r = −0.806, p = 0.001), and number of
steps to turn (r = −0.830, p = 0.001). MDRS Total
scores correlated with one balance measure, mean
sway velocity in the medio-lateral direction (r =
−0.726, p = 0.005). MDRS Total scores had a modest
correlation with motor UPDRS scores in the ON co-
ndition (r = −0.568, p = 0.043). There was no significant
correlation between MDRS Total scores and PIGD scores
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(p = 0.061). Lastly, an association was found between pro-
cessing speed, as measured by the SDMT, and two mea-
sures from the gait turning domain (turn duration and
number of steps to turn), but no other cognitive domain
had significant correlations with any gait domains
(Table 4).
False discovery rate (FDR)
A total of 161 correlations were performed. After FDR
correction, 26 significant associations (Spearman’s rho >
0.2, p < 0.05) was reduced to six significant associations
(bolded in Tables 1 and 2).
Discussion
This pilot study adds to the body of evidence [5, 7,
28–30] that lower global cognitive function is corre-
lated with worse performance in different domains of
gait and balance. Importantly, this is the first study to
demonstrate the correlation between reduced process-
ing speed and impaired turning. Though this is a
small pilot study, the validity of our results are
strengthened by the strong reliability of the APDM
system ([15–17, 31]. Salarian et al. [31] demonstrated
that the APDM Mobility lab system has high test-
retest reliability for turn duration (ρ = 0.89) and good
reliability for the number of steps to turn (ρ = 0.75).
Prior studies [32] have shown that executive func-
tion plays a role in turning, but the domain of ex-
ecutive function may be too broad to provide
meaningful results in a clinical or research context
[33]. Processing speed is a more precise construct as
it is a basic cognitive process that subserves higher-
order cognitive domains such as executive function
[34]. The mechanism of reduced processing speed in
Table 1 Neuropsychological battery: cognitive domains and
corresponding tests
Domain Tests




Rey Auditory Verbal Learning Test (RAVLT) -
Trial 5 [52, 53]
Verbal Memory –
Delayed
Rey Auditory Verbal Learning Test (RAVLT) -
Delayed Recall [52, 53]
Processing speed Symbol Digit Modalities Test (SDMT) [54]
Working memory Auditory Consonant Trigrams (ACT) [55, 56]
Executive function Tower of London (TOL) [57]
Table 2 Participant Characteristics
Mean (SD)
n 14
Age, years 61.1 (7.8)
Age of onset, years 48.5 (10.9)
Height, m 1.72 (0.14)
Weight, kg 82.5 (23.1)
Men/Women % 66.5/33.5
Disease duration, years 12.7 (6.2)
H & Y 2.3 (0.6)
Motor UPDRS 21.5 (9.2)
PIGD 2.7 (3.4)
MDRS 132.2 (8.3)
H & Y Hoehn and Yahr, UPDRS Unified Parkinson’s disease rating scale, PIGD
postural instability/gait disturbance score, MDRS Mattis dementia rating scale





Gait cycle time, sec −0.613 0.034
Cadence, steps/min 0.627 0.029
Stride velocity, % height/sec 0.816 0.001
Stride length, % height 0.687 0.014
RoM leg, degrees 0.687 0.014
Gait – Arm & trunk Movement
Arm peak velocity, deg/s 0.637 0.026
Arm swing RoM, deg 0.007 0.983
Asymmetry arm swing RoM, % −0.193 0.549
ROM trunk frontal plane, deg 0.455 0.137
RoM trunk sagittal plane, deg 0.235 0.463
RoM trunk horizontal plane, deg 0.312 0.324
Gait – Dynamic Stability
Double support time, % of gait cycle −0.504 0.094
Stance time, % of gait cycle −0.504 0.094
Turning
Peak velocity, deg/s 0.682 0.010
Duration, sec −0.806 0.001
Mean step time, sec −0.354 0.259
Number of steps, n −0.830 0.001
Postural sway
Sway RMS AP, m/s2 −0.558 0.047
Sway RMS ML, m/s2 −0.644 0.018
Mean velocity AP, m/s −0.074 0.809
Mean velocity ML, m/s −0.726 0.005
Centroidal frequency AP, Hz −0.297 0.324
Centroidal frequency ML, Hz −0.242 0.426
aBolded measures indicate measures that remained significant after false
discovery rate (FDR) correction
MDRS Mattis dementia rating scale, ROM range of motion, RMS root mean
square of acceleration time series, AP anteroposterior, ML mediolateral,
centroidal frequency (variability of acceleration traces power ranging from
0 to 1)
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Table 4 Correlation of Gait and Balance Domains with Specific Cognitive Domainsa
Language Verbal Memory – Immediate Verbal Memory – Delayed Processing Speed Working Memory Executive Function
COWAT [51] RAVLT Trial 5 [52, 53] RAVLT Delayed Recall [52, 53] SDMT [54] ACT [55, 56] TOL [57]
r p r p r p r p r p r p
Gait – pace
Gait cycle time, sec −0.624 0.040 −0.402 0.221 −0.291 0.385 −0.573 0.083 −0.219 0.571 0.256 0.507
Cadence, steps/min 0.574 0.065 0.420 0.198 0.291 0.385 0.530 0.115 0.310 0.416 −0.183 0.638
Stride velocity, %h/s 0.492 0.124 0.525 0.097 0.517 0.103 0.744 0.014 0.529 0.143 0.146 0.708
Stride length, %h 0.091 0.790 0.388 0.238 0.467 0.148 0.585 0.075 0.785 0.012 0.602 0.086
RoM leg, deg 0.091 0.790 0.388 0.238 0.467 0.148 0.585 0.075 0.785 0.012 0.602 0.086
Gait – arm & trunk Movement
Arm peak velocity, deg/s 0.374 0.258 0.370 0.263 0.342 0.304 0.744 0.014 0.347 0.360 0.091 0.815
Arm swing RoM, deg −0.469 0.145 −0.498 0.119 −0.199 0.558 0.085 0.815 −0.183 0.638 −0.018 0.963
Asymmetry arm swing RoM, % −0.542 0.085 −0.438 0.177 −0.231 0.494 −0.311 0.382 −0.237 0.539 −0.146 0.708
ROM trunk frontal plane, deg −0.287 0.392 0.128 0.708 0.217 0.521 0.335 0.343 0.639 0.064 0.475 0.197
RoM trunk sagittal plane, deg 0.082 0.811 −0.096 0.779 0.000 1.000 0.598 0.068 0.347 0.360 0.110 0.779
RoM trunk horizontal plane, deg −0.369 0.264 −0.233 0.491 −0.037 0.914 0.024 0.947 0.091 0.815 0.183 0.638
Gait – Dynamic Stability
Double support time, % of gait cycle −0.292 0.384 −0.324 0.331 −0.393 0.232 −0.378 0.281 −0.548 0.127 −0.420 0.260
Stance time, % of gait cycle −0.292 0.384 −0.324 0.331 −0.393 0.232 −0.378 0.281 −0.548 0.127 −0.420 0.260
Turning
Peak velocity, deg/s 0.273 0.416 0.548 0.065 0.542 0.069 0.732 0.016 0.649 0.042 0.389 0.266
Duration, sec −0.597 0.053 −0.643 0.024 −0.712 0.009 −0.884 0.001 −0.621 0.055 −0.362 0.304
Mean step time, sec −0.433 0.184 −0.119 0.728 0.032 0.925 −0.354 0.316 −0.164 0.673 0.347 0.360
Number of steps, n −0.409 0.212 −0.700 0.016 −0.400 0.198 −0.954 <0.001 −0.803 0.009 −0.566 0.112
Postural sway
Sway RMS AP, m/s2 −0.410 0.210 −0.366 0.243 −0.400 0.198 −0.220 0.542 −0.382 0.276 −0.464 0.176
Sway RMS ML, m/s2 −0.255 0.449 −0.443 0.149 −0.556 0.061 −0.122 0.737 −0.580 0.079 −0.580 0.079
Mean velocity AP, m/s −0.059 0.863 −0.460 0.132 −0.025 0.939 −0.085 0.815 0.096 0.793 0.096 0.793
Mean velocity ML, m/s −0.410 0.210 −0.633 0.027 −0.609 0.036 −0.256 0.475 −0.574 0.083 −0.437 0.207
Centroidal frequency AP, Hz −0.027 0.936 −0.341 0.278 −0.513 0.088 0.061 0.867 −0.615 0.059 −0.737 0.015
Centroidal frequency ML, Hz 0.077 0.821 −0.429 0.164 −0.517 0.085 0.091 0.802 −0.362 0.304 −0.608 0.062
aBolded measures indicate measures that remained significant after False Discovery Rate (FDR) correction












PD has been explored in several studies. Jokinen et
al. [35] used [18F]fluorodopa (Fdopa) Positron Emmi-
sion Tomography (PET) to demonstrate that reduced
Fdopa uptake in the anterior cingulate gyrus, thal-
amus, and caudate nucleus was related to decreased
processing speed. Likewise, when examining the
predictive role of gray and white matter fractional
anisotropy on processing speed in PD subjects and
controls, Price et al. [36] found that lower prefrontal
fractional anisotropy and caudate nucleus volume
were related to reduced processing speed in PD sub-
jects. Thus, dopaminergic dysfunction in networks
connecting the striatum and prefrontal cortex and caudate
volume loss and dysfunction may be involved in the lower
processing speed observed in PD [35, 37–39].
Identification of processing speed deficits is particu-
larly important since this construct has the potential to
be modified with cognitive training [40–46]. Edwards et
al. [41] demonstrated that PD subjects could improve
cognitive processing speed over a three-month period
through a self-administered task using speed of pro-
cessing training (SOPT) software (InSight). Moreover,
Milman et al. [47] enrolled 18 PD subjects in a 12-
week, computerized cognitive remediation program
and found that subjects improved in both gait turning
speed and duration. Additional studies are needed to
replicate these results and determine whether such
cognitive training methods could translate to im-
proved gait, turning, balance, or other activities of
daily living (ADLs) in PD.
This study also demonstrated that pace-related mea-
sures of gait and postural sway were correlated with
global cognitive scores. We were unable to determine
the cognitive domain(s) driving this association, likely
due to our small sample size. However, prior studies
do provide some insight into the cognitive basis for
dysfunction in the pace and postural sway domains in
PD. Amboni et al. [48] conducted a study in 43 PD
subjects and 20 healthy controls that examined the
associations between cognition and motor function
using an automated sensor-based system generating
eight measures categorized into two domains: (1) gait
pace and (2) postural stability or balance. Results
showed that reduced visuospatial processing was asso-
ciated with worse postural stability and supported
previous studies that describe the importance of pro-
cessing of visual information for locomotion and
motor planning, particularly in PD [49, 50].
In addition to visuospatial function, working memory
may also play a role in postural stability. In a cohort of
121 early PD subjects and 184 healthy controls, Lord et
al. [51] examined the associations between cognition
and motor function using an instrumented walkway sys-
tem (GAITRite, CIR systems, USA) that generated 16
different gait and balance measures. Results showed a
significant association between postural stability and
working memory in PD subjects with the PIGD subtype.
It was hypothesized that changes in postural stability
may be a marker of amnestic features, and that reduced
working memory may reflect cortical amyloid deposition
in the PIGD subtype of PD [51, 52].
Studies have also suggested a possible relationship be-
tween the domain of gait pace and attention [51, 53, 54].
Gait is a goal directed activity, and the finding that at-
tentional circuits are activated through dopaminergic
and cholinergic signaling between the dorsolateral pre-
frontal cortex and the caudate nucleus during gait per-
formance [55] supports this hypothesis. In early PD,
individuals may be able to compensate for pace deficits
by relying more heavily on these attentional circuits [56].
However as the disease progresses and attentional cir-
cuitry becomes increasingly abnormal [57], PD patients
are likely less able to compensate [56] and have reduced
pace as a result [51].
The strengths of our study include the use of quantita-
tive, sensor-based assessments to evaluate gait and bal-
ance that provided objective metrics of motor function,
as well as a neuropsychological testing protocol that in-
cluded global and domain specific cognitive measures.
The limitations of our study include a small sample size
and the use of only one neuropsychological test per cog-
nitive domain. We also did not include a control group,
which would have been helpful in determining which re-
lationships are directly related to PD compared with
normal aging. Despite these limitations, our findings
highlight the value of linking quantitative motor assess-
ments with clinical neuropsychological measures to elu-
cidate the complex interplay between motor and
cognitive function in PD. Overall, this study demon-
strates that there is a relationship between specific cog-
nitive domains and motor function in PD which
warrants further exploration. We showed that impaired
turning is associated with reduced processing speed and
larger studies are needed to validate these findings. The
question of whether cognitive deficits mediate gait and
balance dysfunction or vice versa, or whether there is an
interaction between the two processes is an area of ac-
tive research investigation in PD and other neurodegen-
erative disorders [7].
Conclusions
This is the first study to demonstrate the correlation be-
tween reduced processing speed and impaired turning in
Parkinson’s disease. Identification of processing speed
deficits is particularly important since this construct has
the potential to be modified with cognitive training. Fur-
ther studies are needed to validate these findings.
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Appendix
Table 5 Gait and balance domains with the corresponding instrumented measures [11]
Instrumented Measure Unit of Measure Definition
Gait–pace Pace during straight ahead walking
Gait cycle time s Duration of a complete gait cycle
Cadence steps/min Stepping rate
Stride velocity %h/s Average gait speed normalized for height
Stride length %h Distance between 2 consecutive heel-strikes normalized for height
RoM leg ° Range of motion (RoM) of the leg (calculated from the integrated
sagittal angular velocity, approximation of step length) Average of
the left and right sides
Gait–arm & trunk movement Arm and trunk movement during straight-ahead walking
Arm peak velocity °/s Peak (95 %) angular velocity of most affected arm
Arm swing RoM ° Range of motion of most affected arm during arm swing
Asymmetry arm swing RoM % Average asymmetry of left and right arm swing range of motion
RoM trunk frontal plane ° Average range of motion of trunk in frontal plane
RoM trunk sagittal plane ° Average range of motion of trunk in sagittal plane
RoM trunk horizontal plane ° Average range of motion of trunk in horizontal plane
Gait–dynamic stability Dynamic stability during straight-ahead walking
Double support time % of gait cycle Percentage of a gait cycle that both feet are on the ground
Stance time % of gait cycle Average percentage of a gait cycle that either foot is on the ground
Swing time % of gait cycle Average percentage of a gait cycle that either foot is off the ground
Turning 180° turn
Peak velocity °/s Peak (95 %) angular velocity of trunk during turning
Duration s Duration of a 180° turn
Mean step time s Average duration of step during 180° turn
Number of steps n Total number of steps during 180° turn
Postural sway Standing quietly for 30 s
Sway RMS AP m/s2 Root mean square (RMS) of acceleration time series in anteroposterior
(AP) direction
Sway RMS ML m/s2 Root mean square of acceleration time series in mediolateral (ML)
direction
Mean velocity AP m/s Mean velocity of center of pressure in anteroposterior direction
Mean velocity ML m/s Mean velocity of center of pressure in mediolateral direction
Centroidal frequency AP Hz Centroidal frequency in anteroposterior direction; variability of the
acceleration traces power ranging from 0 to 1
Centroidal frequency ML Hz Centroidal frequency in mediolateral direction; variability of the acceleration
traces power ranging from 0 to 1
Nomenclaturea ° degree, g acceleration of gravity, %h percentage of patient’s height, n number, m/s2 acceleration, s seconds, − dimensionless
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